Cochlear Ltd (ASX: COH) shares brutally plunged in April. But the long-term story remains intact, and a rebound is possible ...

Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...

Cochlear Ltd has updated its trading performance, reducing its FY26 earnings guidance to A$290-330 million. The company anticipates a 2-6% sales growth in the second half, in constant currency.

These ASX healthcare shares have disappointed investors, but their long-term growth stories may still be intact. The post Down over 50%: Are CSL and Cochlear strong buys in May? appeared first on The ...

LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...

One day can ruin years of success... The post Cochlear stock down 40%: How much has this cost ASX investors? appeared first ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

Cochlear also said that trading conditions for implants in developed markets have been softer-than-expected, while the fourth ...

Cochlear further supports Audio Streaming for Hearing Aids (ASHA) standard to enable direct streaming from Fire TV devices to a Cochlear™ hearing implant for the first time. LONE TREE, Colo., Feb. 22, ...

Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! The goal of this article is to teach you how to use price to earnings ratios (P/E ratios).

MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...